Metraipolis › archive › dc_913bf76fac8b
Post-Marketing Safety Surveillance of Autoimmune Diseases Following Bivalent Human Papillomavirus Vaccination in China — Europe PMC PMID:42646704
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42646704
- DOI
- 10.3390/vaccines14080687
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T10:35:29.689Z
- SHA-256 of the archived text
8cf2c8dd92845c496d832e1bac1e54872a6a5723f824c57de29ba0c0e235318f- Stable URL of this page
https://metraipolis.com/documento/dc_913bf76fac8b
How to cite
Post-Marketing Safety Surveillance of Autoimmune Diseases Following Bivalent Human Papillomavirus Vaccination in China — Europe PMC PMID:42646704 — Europe PMC (en), https://europepmc.org/article/MED/42646704 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_913bf76fac8b (Metraipolis archive dc_913bf76fac8b, sha256 8cf2c8dd92845c496d832e1bac1e54872a6a5723f824c57de29ba0c0e235318f)
BibTeX
@misc{dc913bf76fac8b,
title = {Post-Marketing Safety Surveillance of Autoimmune Diseases Following Bivalent Human Papillomavirus Vaccination in China — Europe PMC PMID:42646704},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42646704},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_913bf76fac8b; sha256 8cf2c8dd92845c496d832e1bac1e54872a6a5723f824c57de29ba0c0e235318f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42646704. Agents can read the archived copy with the MCP tool read_document.